HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:
Sign In to gain access to subscriptions and/or personal tools.

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Request Reprints Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (18) Citing Articles via Google Scholar Google Scholar Articles by Borgen, L. A. Articles by Lai, A. Search for Related Content PubMed PubMed Citation Articles by Borgen, L. A. Articles by Lai, A. Social Bookmarking                         What's this?

The Influence of Gender and Food on the Pharmacokinetics of Sodium Oxybate Oral Solution in Healthy Subjects

From Orphan Medical, Inc., Minnetonka, Minnesota (Dr. Borgen); Okerholm & Associates, Palm City, Florida (Dr. Okerholm); Bio-Kinetic Clinical Applications, Springfield, Missouri (Dr. Morrison); and CPKD Solutions, Research Triangle Park, North Carolina (Dr. Lai). Dr. Borgen is a fellow of the American College of Clinical Pharmacology.

Sodium oxybate (Xyrem®; gamma-hydroxybutyrate) oral solution was recently approved in the United States for the treatment of cataplexy in patients with narcolepsy. Two single-center, randomized, open-label studies in healthy volunteers receiving single oral 4.5-g doses of sodium oxybate evaluated effects of (1) gender on oxybate pharmacokinetics and (2) food on its oral bioavailability. In the latter study, one dose was administered after an overnight fast, another after a high-fat meal; 1 week separated treatments. Sodium oxybate pharmacokinetics was not significantly different between sexes. However, food significantly altered the bioavailability of oxybate by decreasing mean peak plasma concentration, increasing median time-to-peak concentration, and decreasing the area under the plasma concentration-time curve. Food did not affect elimination and urinary excretion of unchanged drug. No dose adjustment of sodium oxybate based on sex is indicated. Although significant food effects were observed, these are minimized in patients by the nocturnal dosing of sodium oxybate hours after the evening meal at a consistent time interval following food ingestion.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M. D Lemon, J. D Strain, and D. K Farver Sodium Oxybate for Cataplexy Ann. Pharmacother., March 1, 2006; 40(3): 433 - 440. [Abstract] [Full Text] [PDF]

				L. A. Borgen, R. A. Okerholm, A. Lai, and M. B. Scharf The Pharmacokinetics of Sodium Oxybate Oral Solution following Acute and Chronic Administration to Narcoleptic Patients J. Clin. Pharmacol., March 1, 2004; 44(3): 253 - 257. [Abstract] [Full Text] [PDF]